Clinical development of mTOR inhibitors in breast cancer

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1465-542X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Clinical development of mTOR inhibitors in breast cancer ; volume:16 ; number:1 ; day:17 ; month:2 ; year:2014 ; pages:1-9 ; date:2.2014
Breast cancer research ; 16, Heft 1 (17.2.2014), 1-9, 2.2014

Creator: Vicier, Cecile

Contributor: Dieci, Maria Vittoria
Arnedos, Monica
Delaloge, Suzette
Viens, Patrice
Andre, Fabrice
SpringerLink (Online service)

DOI: 10.1186/bcr3618

URN: urn:nbn:de:1111-2016032419049

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 20.08.2022, 1:05 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Vicier, Cecile
Dieci, Maria Vittoria
Arnedos, Monica
Delaloge, Suzette
Viens, Patrice
Andre, Fabrice
SpringerLink (Online service)

Other Objects (12)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges

Deptor: not only a mTOR inhibitor

mTor Inhibitors for the Treatment of Endometriosis

mTOR inhibitors as radiosensitizers in neuroendocrine neoplasms

Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer

Hochschulschrift

Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom

Practical considerations for the use of mTOR inhibitors

mTOR inhibitor everolimus reduces invasiveness of melanoma cells

mTOR inhibitor Everolimus-induced apoptosis in melanoma cells

Perfect match: mTOR inhibitors and tuberous sclerosis complex

Activity of EGFR, mTOR and PI3K inhibitors in an isogenic breast cell line model

mTOR inhibition in management of advanced breast cancer

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges

Deptor: not only a mTOR inhibitor

mTor Inhibitors for the Treatment of Endometriosis

mTOR inhibitors as radiosensitizers in neuroendocrine neoplasms

Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer

Hochschulschrift

Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom

Practical considerations for the use of mTOR inhibitors

mTOR inhibitor everolimus reduces invasiveness of melanoma cells

mTOR inhibitor Everolimus-induced apoptosis in melanoma cells

Perfect match: mTOR inhibitors and tuberous sclerosis complex

Activity of EGFR, mTOR and PI3K inhibitors in an isogenic breast cell line model

mTOR inhibition in management of advanced breast cancer

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges

Deptor: not only a mTOR inhibitor

mTor Inhibitors for the Treatment of Endometriosis

mTOR inhibitors as radiosensitizers in neuroendocrine neoplasms

Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer

Hochschulschrift

Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom

Practical considerations for the use of mTOR inhibitors

mTOR inhibitor everolimus reduces invasiveness of melanoma cells

mTOR inhibitor Everolimus-induced apoptosis in melanoma cells

Perfect match: mTOR inhibitors and tuberous sclerosis complex

Activity of EGFR, mTOR and PI3K inhibitors in an isogenic breast cell line model

mTOR inhibition in management of advanced breast cancer

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Clinical development of mTOR inhibitors in breast cancer

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges

Deptor: not only a mTOR inhibitor

mTor Inhibitors for the Treatment of Endometriosis

mTOR inhibitors as radiosensitizers in neuroendocrine neoplasms

Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer

Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom

Practical considerations for the use of mTOR inhibitors

mTOR inhibitor everolimus reduces invasiveness of melanoma cells

mTOR inhibitor Everolimus-induced apoptosis in melanoma cells

Perfect match: mTOR inhibitors and tuberous sclerosis complex

Activity of EGFR, mTOR and PI3K inhibitors in an isogenic breast cell line model

mTOR inhibition in management of advanced breast cancer

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges

Deptor: not only a mTOR inhibitor

mTor Inhibitors for the Treatment of Endometriosis

mTOR inhibitors as radiosensitizers in neuroendocrine neoplasms

Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer

Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom

Practical considerations for the use of mTOR inhibitors

mTOR inhibitor everolimus reduces invasiveness of melanoma cells

mTOR inhibitor Everolimus-induced apoptosis in melanoma cells

Perfect match: mTOR inhibitors and tuberous sclerosis complex

Activity of EGFR, mTOR and PI3K inhibitors in an isogenic breast cell line model

mTOR inhibition in management of advanced breast cancer

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges

Deptor: not only a mTOR inhibitor

mTor Inhibitors for the Treatment of Endometriosis

mTOR inhibitors as radiosensitizers in neuroendocrine neoplasms

Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer

Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom

Practical considerations for the use of mTOR inhibitors

mTOR inhibitor everolimus reduces invasiveness of melanoma cells

mTOR inhibitor Everolimus-induced apoptosis in melanoma cells

Perfect match: mTOR inhibitors and tuberous sclerosis complex

Activity of EGFR, mTOR and PI3K inhibitors in an isogenic breast cell line model

mTOR inhibition in management of advanced breast cancer

Related objects

Reset password